Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 1
2014 2
2018 4
2019 2
2020 4
2021 2
2022 6
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.
Müller-Jensen L, Knauss S, Ginesta Roque L, Schinke C, Maierhof SK, Bartels F, Finke C, Rentzsch K, Ulrich C, Mohr R, Stenzel W, Endres M, Boehmerle W, Huehnchen P. Müller-Jensen L, et al. Among authors: huehnchen p. Front Immunol. 2023 Feb 8;14:1108116. doi: 10.3389/fimmu.2023.1108116. eCollection 2023. Front Immunol. 2023. PMID: 36845122 Free PMC article.
Immune signatures of checkpoint inhibitor-induced autoimmunity-A focus on neurotoxicity.
Müller-Jensen L, Schulz AR, Mei HE, Mohr R, Ulrich C, Knape P, Frost N, Frischbutter S, Kunkel D, Schinke C, Ginesta Roque L, Maierhof SK, Nickel FT, Heinzerling L, Endres M, Boehmerle W, Huehnchen P, Knauss S. Müller-Jensen L, et al. Among authors: huehnchen p. Neuro Oncol. 2024 Feb 2;26(2):279-294. doi: 10.1093/neuonc/noad198. Neuro Oncol. 2024. PMID: 37823709
Cognitive impairment after cytotoxic chemotherapy.
Huehnchen P, van Kampen A, Boehmerle W, Endres M. Huehnchen P, et al. Neurooncol Pract. 2020 Jan;7(1):11-21. doi: 10.1093/nop/npz052. Epub 2019 Nov 4. Neurooncol Pract. 2020. PMID: 32257280 Free PMC article. Review.
Neurofilament proteins as a potential biomarker in chemotherapy-induced polyneuropathy.
Huehnchen P, Schinke C, Bangemann N, Dordevic AD, Kern J, Maierhof SK, Hew L, Nolte L, Körtvelyessy P, Göpfert JC, Ruprecht K, Somps CJ, Blohmer JU, Sehouli J, Endres M, Boehmerle W. Huehnchen P, et al. JCI Insight. 2022 Mar 22;7(6):e154395. doi: 10.1172/jci.insight.154395. JCI Insight. 2022. PMID: 35133982 Free PMC article.
Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
Müller-Jensen L, Zierold S, Versluis JM, Boehmerle W, Huehnchen P, Endres M, Mohr R, Compter A, Blank CU, Hagenacker T, Meier F, Reinhardt L, Gesierich A, Salzmann M, Hassel JC, Ugurel S, Zimmer L, Banks P, Spain L, Soon JA, Enokida T, Tahara M, Kähler KC, Seggewiss-Bernhardt R, Harvey C, Long GV, Schöberl F, von Baumgarten L, Hundsberger T, Schlaak M, French LE, Knauss S, Heinzerling LM. Müller-Jensen L, et al. Among authors: huehnchen p. Eur J Cancer. 2022 Nov;175:224-235. doi: 10.1016/j.ejca.2022.08.009. Epub 2022 Sep 22. Eur J Cancer. 2022. PMID: 36155116 Free article.
Dataset for: Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune-related adverse events.
Müller-Jensen L, Knauss S, Ginesta Roque L, Schinke C, Maierhof SK, Bartels F, Finke C, Rentzsch K, Ulrich C, Mohr R, Stenzel W, Endres M, Boehmerle W, Huehnchen P. Müller-Jensen L, et al. Among authors: huehnchen p. Data Brief. 2024 Jan 18;53:110062. doi: 10.1016/j.dib.2024.110062. eCollection 2024 Apr. Data Brief. 2024. PMID: 38317734 Free PMC article.
25 results